Dimerix inks agreement for development, commercialisation of kidney disease drug in Japan
Biopharmaceutical company Dimerix Ltd (ASX:DXB) has partnered with Japanese company FUSO to…
Dimerix Limited (ASX:DXB)
About Dimerix Limited
Key Information
DXB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 13/01/2025 | Application for quotation of securities - DXB | 15.57KB | 493 |
| 07/01/2025 | Investor Presentation | 7.1MB | 7.6K |
| 07/01/2025 | Price Sensitive PS Dimerix enters Development and License Agreement for Japan | 357.12KB | 49K |
| 30/12/2024 | Price Sensitive PS DMX-200 ACTION3 Phase 3 Trial Part 2 Recruitment Complete | 350.16KB | 41K |
| 16/12/2024 | Application for quotation of securities - DXB | 15.57KB | 542 |
| 20/11/2024 | Price Sensitive PS Successful planned IDMC review of ACTION3 trial | 258.63KB | 15K |
| 18/11/2024 | Investor Presentation | 5.44MB | 26K |
| 15/11/2024 | Price Sensitive PS Dimerix Receives $7.9M R&D Tax Incentive Rebate | 338.36KB | 8.0K |